DrugCite
Search

MELOXICAM

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Meloxicam Adverse Events Reported to the FDA Over Time

How are Meloxicam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Meloxicam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Meloxicam is flagged as the suspect drug causing the adverse event.

Most Common Meloxicam Adverse Events Reported to the FDA

What are the most common Meloxicam adverse events reported to the FDA?

Diarrhoea
68 (1.45%)
Completed Suicide
67 (1.43%)
Drug Ineffective
65 (1.38%)
Dizziness
63 (1.34%)
Vomiting
61 (1.3%)
Drug Interaction
56 (1.19%)
Gastrointestinal Haemorrhage
53 (1.13%)
Anaemia
45 (.96%)
Nausea
44 (.94%)
Confusional State
41 (.87%)
Headache
39 (.83%)
Show More Show More
Fatigue
38 (.81%)
Haemoglobin Decreased
37 (.79%)
Pain
36 (.77%)
Renal Failure Acute
36 (.77%)
Arthralgia
34 (.72%)
Melaena
33 (.7%)
Blood Pressure Increased
31 (.66%)
Convulsion
31 (.66%)
Renal Impairment
31 (.66%)
Pyrexia
30 (.64%)
Asthenia
29 (.62%)
Rectal Haemorrhage
29 (.62%)
Dyspnoea
28 (.6%)
Pruritus
28 (.6%)
Tremor
28 (.6%)
Abdominal Pain Upper
27 (.57%)
Fibromyalgia
27 (.57%)
Rash
27 (.57%)
Duodenal Ulcer
26 (.55%)
Abdominal Pain
25 (.53%)
Chest Pain
25 (.53%)
Death
25 (.53%)
Oedema Peripheral
25 (.53%)
Urticaria
25 (.53%)
Acute Generalised Exanthematous Pus...
24 (.51%)
Atrial Fibrillation
24 (.51%)
Gastritis
24 (.51%)
Condition Aggravated
23 (.49%)
Haemorrhage
23 (.49%)
Gastric Ulcer
22 (.47%)
Pain In Extremity
22 (.47%)
Drug Hypersensitivity
21 (.45%)
Malaise
21 (.45%)
Transient Ischaemic Attack
21 (.45%)
Gastric Haemorrhage
20 (.43%)
Haematocrit Decreased
20 (.43%)
Hallucination
20 (.43%)
Hypertension
20 (.43%)
Somnolence
20 (.43%)
Tinnitus
20 (.43%)
Faeces Discoloured
19 (.4%)
Balance Disorder
18 (.38%)
Delirium
18 (.38%)
Feeling Abnormal
18 (.38%)
Insomnia
18 (.38%)
Loss Of Consciousness
18 (.38%)
Myocardial Infarction
18 (.38%)
Cardiac Arrest
17 (.36%)
Fall
17 (.36%)
Gait Disturbance
17 (.36%)
Hyperkalaemia
17 (.36%)
Abdominal Discomfort
16 (.34%)
Arthritis
16 (.34%)
Diverticulum
16 (.34%)
Haematemesis
16 (.34%)
Lethargy
16 (.34%)
Respiratory Arrest
16 (.34%)
Back Pain
15 (.32%)
Coronary Artery Disease
15 (.32%)
Hypotension
15 (.32%)
Therapeutic Response Unexpected Wit...
15 (.32%)
Thrombocytopenia
15 (.32%)
Upper Gastrointestinal Haemorrhage
15 (.32%)
Dehydration
14 (.3%)
Eye Movement Disorder
14 (.3%)
Joint Swelling
14 (.3%)
Muscle Spasms
14 (.3%)
Musculoskeletal Stiffness
14 (.3%)
Rash Pruritic
14 (.3%)
White Blood Cell Count Decreased
14 (.3%)
Blood Creatinine Increased
13 (.28%)
Chromaturia
13 (.28%)
Constipation
13 (.28%)
Depressed Level Of Consciousness
13 (.28%)
Gastrooesophageal Reflux Disease
13 (.28%)
Haematochezia
13 (.28%)
Pneumonia
13 (.28%)
Pulmonary Embolism
13 (.28%)
Rash Erythematous
13 (.28%)
Syncope
13 (.28%)
Weight Increased
13 (.28%)
Cardio-respiratory Arrest
12 (.26%)
Duodenitis
12 (.26%)
Gastric Ulcer Haemorrhage
12 (.26%)
Heart Rate Increased
12 (.26%)
Intentional Drug Misuse
12 (.26%)
Muscular Weakness
12 (.26%)
Renal Failure
12 (.26%)
Tachycardia
12 (.26%)
Toxic Epidermal Necrolysis
12 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Meloxicam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meloxicam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Meloxicam

What are the most common Meloxicam adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Meloxicam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Meloxicam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Meloxicam According to Those Reporting Adverse Events

Why are people taking Meloxicam, according to those reporting adverse events to the FDA?

Rheumatoid Arthritis
647
Drug Use For Unknown Indication
579
Product Used For Unknown Indication
546
Arthritis
443
Pain
366
Osteoarthritis
281
Show More Show More
Arthralgia
167
Back Pain
112
Antiinflammatory Therapy
63
Inflammation
58
Psoriatic Arthropathy
56
Ankylosing Spondylitis
39
Intervertebral Disc Protrusion
37
Fibromyalgia
28
Musculoskeletal Pain
26
Spondylitis
25
Pain In Extremity
24
Analgesic Therapy
16
Neck Pain
14
Headache
13
Gout
12
Tendonitis
12
Arthropathy
11
Back Disorder
11
Myalgia
11
Juvenile Arthritis
10
Joint Swelling
10
Bone Pain
8
Ill-defined Disorder
8
Multiple Myeloma
8
Intervertebral Disc Degeneration
7
Exostosis
7
Allergy Test
6
Neuralgia
6
Multiple Sclerosis
6
Osteoporosis Prophylaxis
6
Spinal Osteoarthritis
6
Hypertension
6
Procedural Pain
6
Bursitis
6
Cancer Pain
6
Sciatica
5
Gastrooesophageal Cancer
5
Cardiac Disorder
5
Osteoporosis
5
Muscle Spasms
5
Pain In Jaw
5
Swelling
4
Joint Stiffness
4
Ligament Sprain
4
Pleuritic Pain
4

Drug Labels

LabelLabelerEffective
MeloxicamBryant Ranch Prepack07-MAR-07
MeloxicamPD-Rx Pharmaceuticals, Inc.23-APR-09
Meloxicam Rebel Distributors Corp.01-JUN-09
MeloxicamUDL Laboratories, Inc.19-NOV-09
MobicPhysicians Total Care, Inc.01-APR-10
MeloxicamApotex Corp12-MAY-10
MeloxicamPhysicians Total Care, Inc.22-JUL-10
MeloxicamCarlsbad Technology, Inc28-SEP-10
MeloxicamMedVantx, Inc.14-OCT-10
MeloxicamNCS HealthCare of KY, Inc dba Vangard Labs14-DEC-10
MeloxicamUnit Dose Services16-MAR-11
Meloxicam PD-Rx Pharmaceuticals, Inc.16-MAR-11
MeloxicamUnit Dose Services16-MAR-11
MeloxicamZydus Pharmaceuticals (USA) Inc.28-APR-11
MeloxicamMedVantx, Inc.28-APR-11
MeloxicamMedVantx, Inc.28-APR-11
MeloxicamCadila Healthcare Limited29-APR-11
Meloxicam REMEDYREPACK INC. 03-MAY-11
MeloxicamCardinal Health17-MAY-11
MeloxicamBlenheim Pharmacal, Inc.08-JUN-11
MeloxicamBlenheim Pharmacal, Inc.08-JUN-11
MeloxicamRoxane Laboratories, Inc.01-JUL-11
MeloxicamREMEDYREPACK INC. 18-JUL-11
Trepoxicam-7.5Physician Therapeutics LLC01-AUG-11
MeloxicamSTAT RX USA LLC18-AUG-11
MeloxicamREMEDYREPACK INC. 23-AUG-11
MeloxicamREMEDYREPACK INC. 24-AUG-11
MeloxicamREMEDYREPACK INC. 30-AUG-11
MeloxicamInternational Labs, Inc.31-AUG-11
MeloxicamREMEDYREPACK INC. 08-SEP-11
MeloxicamInternational Labs, Inc.16-SEP-11
MeloxicamLake Erie Medical DBA Quality Care Products LLC01-DEC-11
MeloxicamLake Erie Medical & Surgical Supply DBA Quality Care Products LLC01-DEC-11
MeloxicamMcKesson Contract Packaging10-JAN-12
MeloxicamPreferred Pharmaceuticals, Inc14-FEB-12
Meloxicam Life Line Home Care Services, Inc.21-FEB-12
MeloxicamInternational Labs, Inc.22-FEB-12
MeloxicamSTAT Rx USA LLC23-FEB-12
MobicBoehringer Ingelheim Pharmaceuticals, Inc.15-MAR-12
Mobic PD-Rx Pharmaceuticals, Inc.15-MAR-12
MeloxicamGlenmark Generics Inc., USA31-MAY-12
MeloxicamMylan Pharmaceuticals Inc.30-JUN-12
MeloxicamLake Erie Medical & Surgical Supply DBA Quality Care Products LLC09-JUL-12
MeloxicamPD-Rx Pharmaceuticals, Inc.18-JUL-12
MeloxicamUnichem Pharmaceuticals (USA), Inc.18-JUL-12
MeloxicamMedsource Pharmaceuticals24-JUL-12
MeloxicamTeva Pharmaceuticals USA Inc25-JUL-12
MeloxicamAidarex Pharmaceuticals LLC28-SEP-12
Meloxicam AvPAK09-OCT-12
MeloxicamLake Erie Medical DBA Quality Care Products LLC20-NOV-12
MeloxicamInternational Labs, Inc.03-DEC-12
MeloxicamLupin Pharmaceuticals, Inc.07-JAN-13
Meloxicam Lake Erie Medical DBA Quality Care Products LLC14-FEB-13
MeloxicamAurobindo Pharma Limited18-FEB-13
MeloxicamPreferred Pharmaceuticals, Inc.15-MAR-13
MeloxicamCardinal Health22-MAR-13
MeloxicamTeva Pharmaceuticals USA Inc25-APR-13

Meloxicam Case Reports

What Meloxicam safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Meloxicam. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Meloxicam.